Pipeline Assessment

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Assessment of pipeline activities around client’s area of interest to support strategic decisions

Problem Statement:

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. They wished to identify currently active T-Cell Receptor (TCR) products in research and development for cancer treatment.

Our Methodology:
  • Detailed Assessment of pipeline activity of T-Cell Receptor (TCR) products
  • Clinical Trial Assessment of Clinical Stage products of T-Cell Receptor (TCR) arena
  • Company Assessment via Funding/Collaboration/Partnership Analysis
  • Analyst Comments on R&D developments
Results:
  • Detailed pipeline profiles of T-Cell Receptor (TCR) products
  • Additional comments on Inactive (Discontinued and Dormant) products.
  • Therapeutic assessment of active pipeline products
  • Detailed profiles of Companies with key coverage of collaboration/partnering activities

Related Insights

Due Diligence
Due Diligence

A medium pharmaceutical client with capabilities in novel formulations was involved in a deal with a manufacturing company for commercial-scale manufacturing of the client’s therapies. [...]

View Case
R&D Analysis
R&D Analysis

A mid-Pharma client based in India involved DelveInsight to assist in gathering and analyzing congress abstracts and literature review from various congresses for Parkinson’s disease. [...]

View Case
Out-Licensing Opportunity
Out-Licensing Opportunity

A Small Pharmaceutical Client Based At Sweden, Europe With Capabilities Around A Neonatal Mesenchymal Cells Involved DelveInsight [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.